Tenaya Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Tenaya Therapeutics, Inc. (TNYA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents4.3245.6895.27251.30128.54
Short-Term Investments57.1258.9691.26213.170.00
Cash & Short-Term Investments61.45104.64186.53251.30128.54
Accounts Receivable0.000.002.250.000.00
Inventory0.000.000.000.000.00
Other Current Assets5.095.780.941.471.43
Total Current Assets67.38111.58193.75255.36129.96
Non-Current Assets
Property, Plant & Equipment (Net)47.7553.2662.7054.7117.19
Long-Term Investments0.000.0017.700.000.00
Other Non-Current Assets4.825.684.794.131.01
Total Non-Current Assets52.5758.9385.1958.830.00
Total Assets119.94170.52278.95314.19148.16
Current Liabilities
Accounts Payable5.165.639.5819.781.02
Short-Term Debt2.780.000.000.000.00
Accrued Liabilities7.4712.033.706.032.81
Other Current Liabilities0.210.480.550.161.22
Total Current Liabilities15.9822.7324.2521.775.04
Non-Current Liabilities
Long-Term Debt10.838.1111.0913.710.00
Other Non-Current Liabilities0.280.250.230.183.68
Total Non-Current Liabilities11.118.3611.3213.890.00
Total Liabilities27.0931.0935.5735.668.72
Stockholders' Equity
Common Stock0.010.010.010.000.00
Retained Earnings-514.41-403.28-279.20-155.67-82.81
Accumulated Other Comprehensive Income0.03-0.11-0.38-0.14-0.09
Additional Paid-in Capital607.23542.81522.95434.200.00
Shares Outstanding86.5468.3366.8641.290.00
Total Stockholders' Equity92.85139.42243.38278.53139.44
Total Liabilities & Equity119.94170.52278.95314.190.00